intramuscularly administered methylprednisolone sodium phosphate ( medrol stabisol ) in single doses of 40 , 80 , or 160 mg ( methylprednisolone equivalents ) had a similar effect as the same doses of methylprednisolone sodium succinate ( solu-medrol ) with regard to eosinophil suppression , elevation of glucose , white blood count differential shifts ( lympholytic effect ) , urinary excretion of sodium and potassium , and localized ( pain ) and systemic side effects .
C0700546
methylprednisolone sodium succinate
C0701466
solu-medrol